... identified as the cellular homolog of the avian s...been shown to be almost identical to c-Jun in thei...zation and DNA binding, whereas their N-terminal d...vation, diverge. Antigen: The antibody was pro...
Mouse Anti-Yersinia pestis Capsular F1 Antigen Monoclonal Antibody, Unconjugated, Clone YBF19 from QED Bioscience Inc.
Rabbit Anti-JMJD2D Polyclonal Antibody, Unconjugated from Abcam
Perm/Wash Buffer from BD Biosciences Pharmingen
Biology Products:(Date:11/4/2009)...CARLSBAD, Calif., Nov. 4 GenVault ...lliam Brody, M.D., Ph.D., has joined its Board of ...al Chair of the Salk Institute, is an acclaimed ph... joining the Salk Institute, Dr. Brody served as p... member of the National Academy of Engineering and...
(Date:11/3/2009)...LLEIDA, SPAINIn a research report published in a r... Iglesias and Sim Alegre examined the effects of c...uit color, fruit quality, canopy light distributio...eriments were performed using Extenday and Solarma...st in orchards of ,Mondial Gala, apples. The resea...
(Date:11/3/2009)...FORT COLLINS, COConsumer interest in new and diver...rs including the growth of the "local foods" movem...ports touting its numerous health benefits, demand...ing throughout the U.S. , While most grocery sto... (which is most often imported), varieties of "har...
Breaking Biology News(10 mins):Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Reflective film can boost profits for apple growers 2Sustainably grown garlic 2Sustainably grown garlic 3New Study of House Health Reform Bill 3A Kansas Faces Over 24373 Million in Medicare Funded Nursing Home Cuts Over Ten Years 55031 1New Study of House Health Reform Bill 3A Kansas Faces Over 24373 Million in Medicare Funded Nursing Home Cuts Over Ten Years 55031 2New treatments offer better survival and fresh challenges in colorectal cancer 55026 1New treatments offer better survival and fresh challenges in colorectal cancer 55026 2New treatments offer better survival and fresh challenges in colorectal cancer 55026 3PCAST Members Advise President on Future of Healthcare Energy 55024 1PCAST Members Advise President on Future of Healthcare Energy 55024 2(Date:11/5/2009)... 5 GenVec, Inc. (Nasdaq:... the third quarter ended September 30, 2009. GenVe...hare) for the three months ended September 30, 200...r share) in the comparable quarter of 2008. For th...et loss was $14.1 million ($0.15 per share), compa...
(Date:11/5/2009)... Nov. 5 ThermoGenesis Co...tive products for processing and storing adult ste...ter of fiscal 2010. ,, For the quarter ended Se... $5.2 million, a 15 percent increase over revenues...The Company said the key contributors to the growt...
(Date:11/5/2009)... 5 Cepheid (Nasdaq: CPH...eaking at the following investor conferences, and ... Credit Suisse Healthcare Conferenc...ber, 2009 at 10 a.m. Mountain Time, ...nd, Tuesday, 1 December, 2009 at 1...
(Date:11/5/2009)...PRNewswire/ -- SpineSmith Partners has signed an i... a unique scaffold that mimics the structure of na...veral commercial products by SpineSmith,s Research...the GenOsteo scaffold represents a significant adv...deal environment for the delivery of adult stem ce...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Cepheid to Webcast Upcoming Financial Presentations 2SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2